Dobri Kiprov, M.D., H.P. (ASCP)
Internationally renowned pioneer and expert in Therapeutic Apheresis, Immunotherapy, Long Covid and Age Related Disorders
Dr. Kiprov has worked in the field of Therapeutic Apheresis for more than 30 years and has published extensively on this subject. Dr. Kiprov served two terms on the American Society for Apheresis (ASFA) Board of Directors and created the first ASFA educational video program. He is also the first physician to take and pass the Hemapheresis Practitioner Exam (ASCP). Dr. Kiprov is the recipient of the ASFA Presidential Award for his pioneering work and numerous contributions to the field of apheresis and the Society. He is also the recipient of the ASFA Lecturers Award and the Francis Morrison Memorial Award.
Dr. Kiprov is one of the first physicians in the United States to complete a formal fellowship program in Clinical Immunology and Immunopathology (Massachusettes General Hospital and Harvard Medical School, sponsored by the NIH). Dr. Kiprov’s accomplishments in the field of Immunology are reflected in his numerous publications including the first description of new Immunologically Related Syndromes. With his immunology and apheresis background, Dr. Kiprov has been a part of the first trials of immunotherapy (cell therapies) and is currently involved in several projects involving Cell vaccines and CAR-T cell therapies.
Dr. Kiprov was the first to publish on the effect of Therapeutic Plasma Exchange (TPE) on: